Searched for
FDA APPLICATION
Punjab drug body finds critical lapses at Jackson Laboratories' manufacturing facility in AmritsarThe Punjab FDA has taken decisive action by revoking the manufacturing licence of Jackson Laboratories in Amritsar due to severe regulatory...- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- In 1987, ophthalmologist Dr. Jean Carruthers noticed her crossed-eye patients' frown lines were vanishing, and Botox accidentally became cosmetic history's biggest hitOriginally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...
- In the 1930s, rubber factory workers drank alcohol and suddenly felt sick. It wasn't just a workplace illness, it led to the discovery of Antabuse, helping millions quit drinkingAn accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- In 1907, a chemist tried replacing shellac for cables and searched for a better wire coating, which ended up creating the world’s first synthetic plasticA chemist named Leo Baekeland sought an alternative to shellac in 1907. His research led to Bakelite, the first synthetic plastic. This mat...
- Indian companies among firms yet to pay annual facility fees to FDAFDA has named at least five Indian companies among 43 drugmakers that have failed to meet their annual facility fee payment obligations.
- Ranbaxy Laboratories withdraws applications of 27 drugs filed with USFDARanbaxy Laboratories has agreed to withdraw applications of 27 drugs filed with the US Foods and Drug Administration.
- US court rejects Mylan plea against RanbaxyA US court has dismissed Mylan’s attempt to prevent Ranbaxy from launching a low-cost version of Lipitor in Nov, expected to bring $550-600...
- USFDA nod likely for Ranbaxy generic drugThe US drug regulator has opposed American firm Mylan Inc's request to strip Ranbaxy Laboratories of its six-month exclusive rights to sell...
- Ranbaxy rebounds a day after Mylan sues FDA to block Lipitor copyMylan Pharma has sued the US FDA, seeking to terminate Ranbaxy's exclusive marketing rights to sell a lowcost version of Lipitor for six mo...
- Mylan sues FDA to block Ranbaxy’s Lipitor copyMylan Pharmaceuticals has sued the US drug regulator, seeking to terminate Ranbaxy Laboratories’ exclusive marketing rights to sell a lowco...
- Ranbaxy seeks USFDA approval for new drugRANBAXY Laboratories has sought the US drug regulator’s approval to sell a new drug in the world’s largest pharma market that has been manu...
- Ranbaxy seeks FDA approval to sell drug from its HP unitRanbaxy Laboratories has sought the US drug regulator’s approval to sell a new drug in the world’s largest pharma market that has been manu...
- Investors at risk as US FDA gets tough with drug cosRecent warning letters issued by US Food and Drug Administration, to manufacturing units of Indian pharmaceutical companies, have significa...
- Daiichi sets up team to solve issues with US FDADaiichi Sankyo, the new owner of India’s largest drugmaker Ranbaxy Laboratories, said it has ‘formed a team’ to solve the ongoing issues wi...
- US regulator charges Ranbaxy of falsifying data, test resultsTo address falsified data, FDA has invoked its Application Integrity Policy (AIP) against Paonta Sahib facility. Factors for successful M&A...
Load More
